Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 985085, 9 pages
http://dx.doi.org/10.4061/2011/985085
Review Article

Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway

1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
2Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia
3School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
4Department of Oncology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland

Received 29 December 2010; Accepted 1 March 2011

Academic Editor: Peter Crouch

Copyright © 2011 Katja Kanninen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Hardy and G. A. Higgins, “Alzheimer's disease: the amyloid cascade hypothesis,” Science, vol. 256, no. 5054, pp. 184–185, 1992. View at Google Scholar · View at Scopus
  2. P. J. Crouch, S. M. E. Harding, A. R. White, J. Camakaris, A. I. Bush, and C. L. Masters, “Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 2, pp. 181–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Selkoe, “Alzheimer's disease: genes, proteins, and therapy,” Physiological Reviews, vol. 81, no. 2, pp. 741–766, 2001. View at Google Scholar · View at Scopus
  4. X. Zhu, B. Su, X. Wang, M. A. Smith, and G. Perry, “Causes of oxidative stress in Alzheimer disease,” Cellular and Molecular Life Sciences, vol. 64, no. 17, pp. 2202–2210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Nunomura, G. Perry, G. Aliev et al., “Oxidative damage is the earliest event in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 8, pp. 759–767, 2001. View at Google Scholar · View at Scopus
  6. K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative diseases and oxidatives stress,” Nature Reviews Drug Discovery, vol. 3, no. 3, pp. 205–214, 2004. View at Google Scholar · View at Scopus
  7. D. Praticò, “Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows,” Annals of the New York Academy of Sciences, vol. 1147, pp. 70–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Castegna, M. Aksenov, V. Thongboonkerd et al., “Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain—part II: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71,” Journal of Neurochemistry, vol. 82, no. 6, pp. 1524–1532, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Korolainen, G. Goldsteins, I. Alafuzoff, J. Koistinaho, and T. Pirttilä, “Proteomic analysis of protein oxidation in Alzheimer's disease brain,” Electrophoresis, vol. 23, no. 19, pp. 3428–3433, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. T. T. Reed, W. M. Pierce, W. R. Markesbery, and D. A. Butterfield, “Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD,” Brain Research, vol. 1274, no. C, pp. 66–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. V. Subbarao, J. S. Richardson, and L. S. Ang, “Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro,” Journal of Neurochemistry, vol. 55, no. 1, pp. 342–345, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Olcese, C. Cao, T. Mori et al., “Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease,” Journal of Pineal Research, vol. 47, no. 1, pp. 82–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Grimes and R. S. Jope, “The multifaceted roles of glycogen synthase kinase 3β in cellular signaling,” Progress in Neurobiology, vol. 65, no. 4, pp. 391–426, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Woodgett, “Molecular cloning and expression of glycogen synthase kinase-3/factor A,” EMBO Journal, vol. 9, no. 8, pp. 2431–2438, 1990. View at Google Scholar · View at Scopus
  16. C. Hooper, R. Killick, and S. Lovestone, “The GSK3 hypothesis of Alzheimer's disease,” Journal of Neurochemistry, vol. 104, no. 6, pp. 1433–1439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Hu, A. N. Begum, M. R. Jones et al., “GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals,” Neurobiology of Disease, vol. 33, no. 2, pp. 193–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Leroy, Z. Yilmaz, and J. P. Brion, “Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration,” Neuropathology and Applied Neurobiology, vol. 33, no. 1, pp. 43–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Pei, T. Tanaka, Y. C. Tung, E. Braak, K. Iqbal, and I. Grundke-Iqbal, “Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain,” Journal of Neuropathology and Experimental Neurology, vol. 56, no. 1, pp. 70–78, 1997. View at Google Scholar · View at Scopus
  20. F. Plattner, M. Angelo, and K. P. Giese, “The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation,” Journal of Biological Chemistry, vol. 281, no. 35, pp. 25457–25465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Pei, E. Braak, H. Braak et al., “Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 9, pp. 1010–1019, 1999. View at Google Scholar · View at Scopus
  22. J. J. Lucas, F. Hernández, P. Gómez-Ramos, M. A. Morán, R. Hen, and J. Avila, “Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice,” EMBO Journal, vol. 20, no. 1-2, pp. 27–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Hoshi, A. Takashima, K. Noguchi et al., “Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 7, pp. 2719–2723, 1996. View at Publisher · View at Google Scholar
  24. C. J. Phiel, C. A. Wilson, V. M.-Y. Lee, and P. S. Klein, “GSK-3α regulates production of Alzheimer's disease amyloid-β peptides,” Nature, vol. 423, no. 6938, pp. 435–439, 2003. View at Publisher · View at Google Scholar
  25. A. Takashima, K. Noguchi, G. Michel et al., “Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β,” Neuroscience Letters, vol. 203, no. 1, pp. 33–36, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Baki, R. L. Neve, Z. Shao, J. Shioi, A. Georgakopoulos, and N. K. Robakis, “Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling,” Journal of Neuroscience, vol. 28, no. 2, pp. 483–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Peineau, C. Taghibiglou, C. Bradley et al., “LTP inhibits LTD in the hippocampus via regulation of GSK3β,” Neuron, vol. 53, no. 5, pp. 703–717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Aplin, G. M. Gibb, J. S. Jacobsen, J. M. Gallo, and B. H. Anderton, “In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3β,” Journal of Neurochemistry, vol. 67, no. 2, pp. 699–707, 1996. View at Google Scholar · View at Scopus
  29. A. Takashima, M. Murayama, O. Murayama et al., “Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9637–9641, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. C. C. Weihl, G. D. Ghadge, S. G. Kennedy, N. Hay, R. J. Miller, and R. P. Roos, “Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB,” Journal of Neuroscience, vol. 19, no. 13, pp. 5360–5369, 1999. View at Google Scholar · View at Scopus
  31. T. Engel, F. Hernández, J. Avila, and J. J. Lucas, “Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3,” Journal of Neuroscience, vol. 26, no. 19, pp. 5083–5090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Hernández, J. Borrell, C. Guaza, J. Avila, and J. J. Lucas, “Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments,” Journal of Neurochemistry, vol. 83, no. 6, pp. 1529–1533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. Q.-L. Ma, G. P. Lim, M. E. Harris-White et al., “Antibodies against β-amyloid reduce Aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro,” Journal of Neuroscience Research, vol. 83, no. 3, pp. 374–384, 2006. View at Publisher · View at Google Scholar
  34. G. A. Turenne and B. D. Price, “Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity,” BMC Cell Biology, vol. 2, no. 1, article 12, p. 12, 2001. View at Google Scholar · View at Scopus
  35. R. S. Jope and G. V. W. Johnson, “The glamour and gloom of glycogen synthase kinase-3,” Trends in Biochemical Sciences, vol. 29, no. 2, pp. 95–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. G. N. Bijur and R. S. Jope, “Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3β in the regulation of HSF-1 activity,” Journal of Neurochemistry, vol. 75, no. 6, pp. 2401–2408, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. B. He, Y.-H. Meng, and N. F. Mivechi, “Glycogen synthase kinase 3β and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6624–6633, 1998. View at Google Scholar
  38. B. P. Bullock and J. F. Habener, “Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge,” Biochemistry, vol. 37, no. 11, pp. 3795–3809, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Jean, M. Harbison, D. J. McConkey, Z. Ronai, and M. Bar-Eli, “CREB and its associated proteins act as survival factors for human melanoma cells,” Journal of Biological Chemistry, vol. 273, no. 38, pp. 24884–24890, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. R. S. Struthers, W. W. Vale, C. Arias, P. E. Sawchenko, and M. R. Montminy, “Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant,” Nature, vol. 350, no. 6319, pp. 622–624, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. C. A. Grimes and R. S. Jope, “Creb DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium,” Journal of Neurochemistry, vol. 78, no. 6, pp. 1219–1232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Y. Lee, S. H. Koh, M. Y. Noh, K. W. Park, Y. J. Lee, and S. H. Kim, “Glycogen synthase kinase-3β activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells,” Brain Research, vol. 1129, no. 1, pp. 89–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Schäfer, S. Goodenough, B. Moosmann, and C. Behl, “Inhibition of glycogen synthase kinase 3β is involved in the resistance to oxidative stress in neuronal HT22 cells,” Brain Research, vol. 1005, no. 1-2, pp. 84–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. J. W. Kaspar, S. K. Niture, and A. K. Jaiswal, “Nrf2:INrf2 (Keap1) signaling in oxidative stress,” Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1304–1309, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Y. Chan, X. L. Han, and Y. W. Kan, “Isolation of cDNA encoding the human NF-E2 protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11366–11370, 1993. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan, “Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 21, pp. 9926–9930, 1994. View at Publisher · View at Google Scholar · View at Scopus
  47. T. W. Kensler, N. Wakabayashi, and S. Biswal, “Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Lee, M. J. Calkins, K. Chan, Y. W. Kan, and J. A. Johnson, “Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis,” Journal of Biological Chemistry, vol. 278, no. 14, pp. 12029–12038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. J. M. Lee, A. Y. Shih, T. H. Murphy, and J. A. Johnson, “NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37948–37956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Li, J. M. Lee, and J. A. Johnson, “Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 388–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. N. M. Inamdar, Y. I. Ahn, and J. Alam, “The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors,” Biochemical and Biophysical Research Communications, vol. 221, no. 3, pp. 570–576, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Li and A. K. Jaiswal, “Regulation of human NAD(P)H: quinone oxidoreductase gene: role of AP1 binding site contained within human antioxidant response element,” Journal of Biological Chemistry, vol. 267, no. 21, pp. 15097–15104, 1992. View at Google Scholar · View at Scopus
  53. R. T. Mulcahy, M. A. Wartman, H. H. Bailey, and J. J. Gipp, “Constitutive and β-naphthoflavone-induced expression of the human γ- glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence,” Journal of Biological Chemistry, vol. 272, no. 11, pp. 7445–7454, 1997. View at Publisher · View at Google Scholar
  54. T. Nguyen, P. Nioi, and C. B. Pickett, “The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291–13295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. H. Rushmore, M. R. Morton, and C. B. Pickett, “The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity,” Journal of Biological Chemistry, vol. 266, no. 18, pp. 11632–11639, 1991. View at Google Scholar · View at Scopus
  56. K. Itoh, N. Wakabayashi, Y. Katoh et al., “Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain,” Genes and Development, vol. 13, no. 1, pp. 76–86, 1999. View at Google Scholar · View at Scopus
  57. A. L. Eggler, G. Liu, J. M. Pezzuto, R. B. Van Breemen, and A. D. Mesecar, “Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 29, pp. 10070–10075, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Kobayashi and M. Yamamoto, “Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species,” Advances in Enzyme Regulation, vol. 46, no. 1, pp. 113–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. K. I. Tong, A. Kobayashi, F. Katsuoka, and M. Yamamoto, “Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism,” Biological Chemistry, vol. 387, no. 10-11, pp. 1311–1320, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. S. B. Cullinan, J. D. Gordan, J. Jin, J. W. Harper, and J. A. Diehl, “The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase,” Molecular and Cellular Biology, vol. 24, no. 19, pp. 8477–8486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Kobayashi, M. I. Kang, H. Okawa et al., “Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2,” Molecular and Cellular Biology, vol. 24, no. 16, pp. 7130–7139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. K. R. Sekhar, X. X. Yan, and M. L. Freeman, “Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2,” Oncogene, vol. 21, no. 44, pp. 6829–6834, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Stewart, E. Killeen, R. Naquin, S. Alam, and J. Alam, “Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium,” Journal of Biological Chemistry, vol. 278, no. 4, pp. 2396–2402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al., “Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11908–11913, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Kobayashi, L. Li, N. Iwamoto et al., “The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds,” Molecular and Cellular Biology, vol. 29, no. 2, pp. 493–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. H. E. de Vries, M. Witte, D. Hondius et al., “Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?” Free Radical Biology and Medicine, vol. 45, no. 10, pp. 1375–1383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Tanaka, Y. Ikeda, Y. Ohta et al., “Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion,” Brain Research, vol. 1370, pp. 246–253, 2011. View at Publisher · View at Google Scholar
  68. W. Jin, H. Wang, W. Yan et al., “Role of Nrf2 in protection against traumatic brain injury in mice,” Journal of Neurotrauma, vol. 26, no. 1, pp. 131–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Y. Shih, P. Li, and T. H. Murphy, “A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo,” Journal of Neuroscience, vol. 25, no. 44, pp. 10321–10335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. von Otter, S. Landgren, S. Nilsson et al., “Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract,” Mechanisms of Ageing and Development, vol. 131, no. 2, pp. 105–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. C. P. Ramsey, C. A. Glass, M. B. Montgomery et al., “Expression of Nrf2 in neurodegenerative diseases,” Journal of Neuropathology and Experimental Neurology, vol. 66, no. 1, pp. 75–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Kanninen, T. M. Malm, H. K. Jyrkkänen et al., “Nuclear factor erythroid 2-related factor 2 protects against beta amyloid,” Molecular and Cellular Neuroscience, vol. 39, no. 3, pp. 302–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Choudhry, D. R. Howlett, J. C. Richardson, P. T. Francis, and P. T. Williams, “Pro-oxidant diet enhances beta/gamma secretase-mediated APP processing in APP/PS1 transgenic mice,” Neurobiology of Aging. In press.
  74. F. Khodagholi, B. Eftekharzadeh, N. Maghsoudi, and P. F. Rezaei, “Chitosan prevents oxidative stress-induced amyloid β formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF-κB,” Molecular and Cellular Biochemistry, vol. 337, no. 1-2, pp. 39–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. W. Ma, L. Yuan, H. Yu et al., “Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by β-amyloid peptides 25-35 in PC12 cells,” International Journal of Developmental Neuroscience, vol. 28, no. 4, pp. 289–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. C. J. Wruck, M. E. Gotz, T. Herdegen, D. Varoga, L. O. Brandenburg, and T. Pufe, “Kavalactones protect neural cells against amyloid β peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation,” Molecular Pharmacology, vol. 73, no. 6, pp. 1785–1795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Eftekharzadeh, N. Maghsoudi, and F. Khodagholi, “Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid β formation in NT2N neurons,” Biochimie, vol. 92, no. 3, pp. 245–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. H. M. Park, J. A. Kim, and M. K. Kwak, “Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome,” Archives of Pharmacal Research, vol. 32, no. 1, pp. 109–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Dostal, C. M. Roberts, and C. D. Link, “Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity,” Genetics, vol. 186, no. 3, pp. 857–866, 2010. View at Publisher · View at Google Scholar
  80. K. Kanninen, R. Heikkinen, T. Malm et al., “Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 38, pp. 16505–16510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Salazar, A. I. Rojo, D. Velasco, R. M. De Sagarra, and A. Cuadrado, “Glycogen synthase kinase-3β inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2,” Journal of Biological Chemistry, vol. 281, no. 21, pp. 14841–14851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. A. I. Rojo, P. Rada, J. Egea, A. O. Rosa, M. G. López, and A. Cuadrado, “Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath,” Molecular and Cellular Neuroscience, vol. 39, no. 1, pp. 125–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. A. K. Jain and A. K. Jaiswal, “Phosphorylation of tyrosine 568 controls nuclear export of Nrf2,” Journal of Biological Chemistry, vol. 281, no. 17, pp. 12132–12142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. A. K. Jain and A. K. Jaiswal, “GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2,” Journal of Biological Chemistry, vol. 282, no. 22, pp. 16502–16510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Y. Kay, Y. W. Kim, D. H. Lee, S. H. Sung, S. J. Hwang, and S. G. Kim, “Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCdelta-GSK3beta pathway,” British Journal of Pharmacology. In press.
  86. S. Espada, A. I. Rojo, M. Salinas, and A. Cuadrado, “The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection,” Journal of Neurochemistry, vol. 110, no. 3, pp. 1107–1119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J. H. An, K. Vranas, M. Lucke et al., “Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 45, pp. 16275–16280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Prestera, W. D. Holtzclaw, Y. Zhang, and P. Talalay, “Chemical and molecular regulation of enzymes that detoxify carcinogens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 7, pp. 2965–2969, 1993. View at Google Scholar · View at Scopus
  89. E. C. Reisinger, P. Kern, M. Ernst et al., “Inhibition of HIV progression by dithiocarb,” Lancet, vol. 335, no. 8691, pp. 679–682, 1990. View at Publisher · View at Google Scholar
  90. S. F. Liu, X. Ye, and A. B. Malik, “Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes,” Circulation, vol. 100, no. 12, pp. 1330–1337, 1999. View at Google Scholar · View at Scopus
  91. R. Schreck, B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle, “Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells,” Journal of Experimental Medicine, vol. 175, no. 5, pp. 1181–1194, 1992. View at Google Scholar · View at Scopus
  92. M. Hayakawa, H. Miyashita, I. Sakamoto et al., “Evidence that reactive oxygen species do not mediate NF-κB activation,” EMBO Journal, vol. 22, no. 13, pp. 3356–3366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Verhaegen, A. J. McGowan, A. R. Brophy, R. S. Fernandes, and T. G. Cotter, “Inhibition of apoptosis by antioxidant in the human HL-60 leukemia cell line,” Biochemical Pharmacology, vol. 50, no. 7, pp. 1021–1029, 1995. View at Publisher · View at Google Scholar · View at Scopus
  94. A. C. Wild, H. R. Moinova, and R. T. Mulcahy, “Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2,” Journal of Biological Chemistry, vol. 274, no. 47, pp. 33627–33636, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. L. M. Zipper and R. T. Mulcahy, “Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells,” Toxicological Sciences, vol. 73, no. 1, pp. 124–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Borrello and B. Demple, “NFκ B-independent transcriptional induction of the human manganous superoxide dismutase gene,” Archives of Biochemistry and Biophysics, vol. 348, no. 2, pp. 289–294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  97. C. L. Hartsfield, J. Alam, and A. M. K. Choi, “Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate,” FASEB Journal, vol. 12, no. 15, pp. 1675–1682, 1998. View at Google Scholar · View at Scopus
  98. K. M. Stuhlmeier, “Activation and regulation of Hsp32 and Hsp70,” European Journal of Biochemistry, vol. 267, no. 4, pp. 1161–1167, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. I. Nobel, M. Kimland, B. Lind, S. Orrenius, and A. F. G. Slater, “Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper,” Journal of Biological Chemistry, vol. 270, no. 44, pp. 26202–26208, 1995. View at Publisher · View at Google Scholar · View at Scopus
  100. G.-Y. Liu, N. Frank, H. Bartsch, and J.-K. Lin, “Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFκB, c-fos/c-jun, and p53 proteins,” Molecular Carcinogenesis, vol. 22, no. 4, pp. 235–246, 1998. View at Google Scholar
  101. J. C. Tsai, M. Jain, C. M. Hsieh et al., “Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 271, no. 7, pp. 3667–3670, 1996. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Chinery, R. D. Beauchamp, Y. Shyr, S. C. Kirkland, R. J. Coffey, and J. D. Morrow, “Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells,” Cancer Research, vol. 58, no. 11, pp. 2323–2327, 1998. View at Google Scholar · View at Scopus
  103. G. Calviello, G. M. Filippi, A. Toesca et al., “Repeated exposure to pyrrolidine-dithiocarbamate induces peripheral nerve alterations in rats,” Toxicology Letters, vol. 158, no. 1, pp. 61–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. K. C. Chung, J. H. Park, C. H. Kim et al., “Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-κB, and MAP kinases,” Journal of Neuroscience Research, vol. 59, no. 1, pp. 117–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Nurmi, G. Goldsteins, J. Närväinen et al., “Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia,” Free Radical Biology and Medicine, vol. 40, no. 10, pp. 1776–1784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. T. M. Malm, H. Iivonen, G. Goldsteins et al., “Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting β-amyloid burden,” Journal of Neuroscience, vol. 27, no. 14, pp. 3712–3721, 2007. View at Publisher · View at Google Scholar
  107. G. W. Verhaegh, M. J. Richard, and P. Hainaut, “Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper,” Molecular and Cellular Biology, vol. 17, no. 10, pp. 5699–5706, 1997. View at Google Scholar · View at Scopus
  108. T. A. Bayer, S. Schäfer, A. Simons et al., “Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 24, pp. 14187–14192, 2003. View at Publisher · View at Google Scholar
  109. C. J. Maynard, R. Cappai, I. Volitakis et al., “Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron,” Journal of Biological Chemistry, vol. 277, no. 47, pp. 44670–44676, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. A. L. Phinney, B. Drisaldi, S. D. Schmidt et al., “In vivo reduction of amyloid-β by a mutant copper transporter,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 14193–14198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. S. H. Chen, J. K. Lin, Y. C. Liang, M. H. Pan, S. H. Liu, and S. Y. Lin-Shiau, “Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex,” European Journal of Pharmacology, vol. 594, no. 1–3, pp. 9–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. G. Filiz, K. A. Price, A. Caragounis, T. Du, P. J. Crouch, and A. R. White, “The role of metals in modulating metalloprotease activity in the AD brain,” European Biophysics Journal, vol. 37, no. 3, pp. 315–321, 2008. View at Publisher · View at Google Scholar · View at Scopus